These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 18945314)
41. Psoriasis and its treatment with adalimumab. Iaconi A; Feldman SR; Balkrishnan R Expert Opin Biol Ther; 2010 Jan; 10(1):133-52. PubMed ID: 20078231 [TBL] [Abstract][Full Text] [Related]
42. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report. Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591 [No Abstract] [Full Text] [Related]
43. Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial. Leonardi C; Langley RG; Papp K; Tyring SK; Wasel N; Vender R; Unnebrink K; Gupta SR; Valdecantos WC; Bagel J Arch Dermatol; 2011 Apr; 147(4):429-36. PubMed ID: 21173304 [TBL] [Abstract][Full Text] [Related]
44. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade). Mang R; Ruzicka T; Stege H Br J Dermatol; 2004 Feb; 150(2):379-80. PubMed ID: 14996123 [No Abstract] [Full Text] [Related]
45. [Treatment of severe psoriasis with anti-TNF-alpha-antibody and methotrexate]. Dalaker M; Bonesrønning JH Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1070-1. PubMed ID: 12760225 [No Abstract] [Full Text] [Related]
46. Adalimumab for treatment of pyoderma gangrenosum. Pomerantz RG; Husni ME; Mody E; Qureshi AA Br J Dermatol; 2007 Dec; 157(6):1274-5. PubMed ID: 17916198 [No Abstract] [Full Text] [Related]
47. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report. Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311 [TBL] [Abstract][Full Text] [Related]
48. Successful treatment of acrodermatitis continua of Hallopeau with sequential combination of calcipotriol and tacrolimus ointments. Brill TJ; Elshorst-Schmidt T; Valesky EM; Kaufmann R; Thaçi D Dermatology; 2005; 211(4):351-5. PubMed ID: 16286746 [TBL] [Abstract][Full Text] [Related]
49. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. Revicki DA; Willian MK; Menter A; Gordon KB; Kimball AB; Leonardi CL; Langley RG; Kimel M; Okun M J Dermatolog Treat; 2007; 18(6):341-50. PubMed ID: 18058494 [TBL] [Abstract][Full Text] [Related]
51. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau. Kazinski K; Joyce KM; Hodson D J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294 [TBL] [Abstract][Full Text] [Related]
52. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report. Passante M; Dastoli S; Nisticò SP; Bennardo L; Patruno C Dermatol Ther; 2020 Jan; 33(1):e13170. PubMed ID: 31762153 [No Abstract] [Full Text] [Related]
58. Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome. van der Kerkhof PC; Steijlen PM; Raymakers RA Br J Dermatol; 1996 Apr; 134(4):754-7. PubMed ID: 8733386 [TBL] [Abstract][Full Text] [Related]
59. Pustular psoriasis and acrodermatitis continua (Hallopeau) need high doses of systemic ciclosporin A. Korstanje MJ; Bessems PJ; Hulsmans RF; van de Staak WJ Dermatologica; 1989; 179(2):90-1. PubMed ID: 2792497 [No Abstract] [Full Text] [Related]